Reckitt Benckiser swings to FY profit, lifts dividend
1st Mar 2023 08:09
(Sharecast News) - Dettol and Nurofen maker Reckitt Benckiser said on Wednesday that it swung to a full-year profit and lifted its dividend as it benefited from higher prices.
Read moreBerenberg lowers target price on 'still mispriced' Reckitt
27th Oct 2022 10:18
(Sharecast News) - Analysts at Berenberg slashed their target price on household goods manufacturer Reckitt from 8,200.0p to 7,050.0p on Thursday but reiterated its 'buy' rating on the "still mispriced" stock.
Read moreReckitt Benckiser narrows sales target as Q3 sales grow
26th Oct 2022 07:10
(Sharecast News) - Consumer goods giant Reckitt Benckiser narrowed its full-year sales target on Wednesday as it posted a jump in third-quarter revenues despite "challenging" market conditions and pointed to strong demand for infant formula in the US.
Read moreReckitt Benckiser CEO Laxman Narasimhan to step down
1st Sep 2022 07:36
(Sharecast News) - Consumer goods giant Reckitt Benckiser said on Thursday that chief executive officer Laxman Narasimhan will step down on September 30.
Read moreReckitt lifts sales guidance after 'strong' first half
27th Jul 2022 07:41
(Sharecast News) - Consumer goods company Reckitt Benckiser lifted its full-year sales outlook on Wednesday following a "strong" first half.
Read moreReckitt considers ditching sale of infant nutrition unit - report
28th Jun 2022 10:59
(Sharecast News) - Reckitt Benckiser is reportedly considering whether to shelve the sale of its infant nutrition unit, as the high-profile deal falls victim to chaos in the industry and worsening financing markets.
Read moreReckitt struggling with sale of infant nutrition business - report
27th May 2022 15:36
(Sharecast News) - Reckitt Benckiser is reportedly struggling with the sale of its infant nutrition unit, with only a small number of private equity funds following through with bids.
Read moreRBC Capital upgrades Reckitt to 'outperform'
18th May 2022 08:26
(Sharecast News) - RBC Capital Markets upgraded Reckitt Benckiser on Wednesday to 'outperform' from 'sector perform' and lifted the price target to 7,000p from 5,900p.
Read moreReckitt Benckiser LFL revenues up 5.6% in Q1
29th Apr 2022 07:38
(Sharecast News) - Consumer goods company Reckitt Benckiser said on Friday that like-for-like revenues had grown in the first quarter of the trading year, driven by continued broad-based growth and market share momentum across all business units and geographies.
Read moreReckitt begins process to transfer ownership of Russian business
13th Apr 2022 15:19
(Sharecast News) - Dettol maker Reckitt Benckiser has begun a process aimed at transferring ownership of its Russian business, which may include a transfer to a third party or to its local employees.
Read moreReckitt posts £804m annual loss but predicts growth
17th Feb 2022 07:08
(Sharecast News) - Reckitt Benckiser suffered an £804m annual operating loss caused by the sale of its Chinese infant formula business but the consumer goods company was upbeat about growth.
Read moreThursday preview: Fedspeak, ECB, Reckitt Benckiser in focus
16th Feb 2022 10:05
(Sharecast News) - Financial markets' focus on Thursday will be on the US Federal Reserve and European Central Bank with top officials from both institutions set to deliver speeches.
Read moreReckitt Benckiser proposes sale of E45 brand to Karo Pharma
24th Dec 2021 07:07
(Sharecast News) - Consumer goods company Reckitt Benckiser has entered into an agreement for the proposed sale of the E45 brand and related sub-brands to Karo Pharma for an implied enterprise value of £200.0m.
Read moreReckitt ups guidance as cold and flu sales rise
26th Oct 2021 07:04
(Sharecast News) - Reckitt Benckiser upgraded its 2021 revenue outlook as sales of cold and flu remedies helped the consumer goods company reported stronger than expected third-quarter trading.
Read moreReckitt ups guidance as cold and flu sales rise
26th Oct 2021 07:04
(Sharecast News) - Reckitt Benckiser upgraded its 2021 revenue outlook as sales of cold and flu remedies helped the consumer goods company reported stronger than expected third-quarter trading.
Read more